There were 1,894 press releases posted in the last 24 hours and 426,657 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image